SCHEMBL5741445

SCHEMBL5741445

COc1ccc(S(=O)(=O)N2CCN(CCc3nc(N(C)Cc4ccccc4)c4ccccc4n3)CC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.53
GBA1 P04062 5/20 0.48
PKM P14618 3/20 0.48
HSD11B1 P28845 1/20 0.46
KMT2A Q03164 3/20 0.46
NPSR1 Q6W5P4 1/20 0.46
ALDH1A1 P00352 4/20 0.45
MEN1 O00255 1/20 0.45
CHRM5 P08912 1/20 0.45
MAPK1 P28482 2/20 0.44
TSHR P16473 1/20 0.44
NPC1 O15118 1/20 0.44
USP2 O75604 1/20 0.44
CFTR P13569 1/20 0.44
POLB P06746 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5742866 0.90 GBA1 (0.54) LMNAGBA1PKMHSD11B1KMT2A
SCHEMBL5743239 0.84 LMNA (0.55) LMNAGBA1PKMHSD11B1KMT2A
SCHEMBL5741270 0.83 LMNA (0.57) LMNAGBA1PKMHSD11B1KMT2A
SCHEMBL5740458 0.82 GBA1 (0.60) LMNAGBA1PKMHSD11B1KMT2A
SCHEMBL5743384 0.82 GBA1 (0.63) LMNAGBA1PKMHSD11B1KMT2A
SCHEMBL5741406 0.82 GBA1 (0.58) LMNAGBA1PKMHSD11B1KMT2A
SCHEMBL5741579 0.82 PDE5A (0.58) LMNAGBA1PKMHSD11B1KMT2A
SCHEMBL5742174 0.81 GBA1 (0.62) LMNAGBA1PKMHSD11B1KMT2A
SCHEMBL5740265 0.81 LMNA (0.53) LMNAGBA1PKMHSD11B1KMT2A
SCHEMBL3820111 0.81 CFTR (0.64) LMNAGBA1PKMHSD11B1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1646615-A1 PYRIMIDINE DERIVATIVES AS MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS Vertex Pharmaceuticals Incorporated (US) 2006-04-19 EP disclosed
WO-2004111014-A1 PYRIMIDINE DERIVATIVES AS MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2004-12-23 WO disclosed